Validation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) Scale
Study Details
Study Description
Brief Summary
The Clinically Useful Depression Outcome Scale (CUDOS) is a brief, self-administered instrument that not only evaluates depressive symptoms but also both functioning and quality of life. The assessment of patients´ perspective may provide valuable information that could be lost if relaying only on clinician evaluation. The purpose of this study is to achieve a psychometric validation into Spanish of the CUDOS scale in patients with major depression disorder in a primary care setting.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Major Depressive Disorder Patients
|
Outcome Measures
Primary Outcome Measures
- Clinically Useful Depression Outcome Scale [up to 12 weeks after a diagnoses of a major depressive disorder]
To analyze feasibility and reliability (internal consistency - Cronbach´s alpha) of the Spanish version of the scale
Secondary Outcome Measures
- Hamilton Depression Rating Scale [up to 12 weeks after a diagnoses of a major depressive disorder]
To analyze convergent validity of the Spanish version of the CUDOS scale
- SF 36 [up to 12 weeks after a diagnoses of a major depressive disorder]
To analyze correlation in quality of life -item 18 of the CUDOS scale
- Patient Global Impression Scale [up to 12 weeks after a diagnoses of a major depressive disorder]
To analyze criterion validity of the Spanish version of the CUDOS scale
- Social Occupational Functioning Scale [up to 12 weeks after a diagnoses of a major depressive disorder]
To analyze correlation in functioning -item 17 of the CUDOS scale
- Clinically Global Impression Scale [up to 12 weeks after a diagnoses of a major depressive disorder]
To analyze criterion validity of the Spanish version of the CUDOS scale
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Major depression disorder diagnosis according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) criteria in the last 3 months
-
Major depression disorder diagnosis according to Prime-MD criteria in the last 3 months
Exclusion Criteria:
-
Be unable to understand and comply with the study requirements as judged by the investigator
-
Participation in another trial prior to enrolment into this study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Research Site | A Coruña | Spain | ||
2 | Research Site | Barcelona | Spain | ||
3 | Research Site | Cadiz | Spain | ||
4 | Research Site | Cordoba | Spain | ||
5 | Research Site | El Vendrell | Spain | ||
6 | Research Site | Granada | Spain | ||
7 | Research Site | Huelva | Spain | ||
8 | Research Site | Lugo | Spain | ||
9 | Research Site | Madrid | Spain | ||
10 | Research Site | Majadahonda | Spain | ||
11 | Research Site | Malaga | Spain | ||
12 | Research Site | Nigran | Spain | ||
13 | Research Site | Palma Mallorca | Spain | ||
14 | Research Site | Salamanca | Spain | ||
15 | Research Site | Terrasa | Spain | ||
16 | Research Site | Tudela | Spain | ||
17 | Research Site | Vigo | Spain |
Sponsors and Collaborators
- AstraZeneca
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NIS-NES-XXX-2011/1